Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
abbvie
5
×
biotech
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
detroit blog main
detroit top stories
indiana blog main
indiana top stories
life sciences
merck
5
×
national
national blog main
national top stories
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
5
×
deals
novartis
pfizer
startups
alzheimer's disease
astrazeneca
bristol-myers squibb
cancer
cancer immunotherapy
diagnostics
drug prices
What
drug
5
×
bio
roundup
acquisitions
biggest
ceo
companies
nash
news
today
albert
approval
approved
away
biogen’s
biopharmaceutical
bourla
bringing
build
buy
ceos
company
company’s
convo
crispr
daniel
dc
debut
digital
disease
dyne’s
earlier
epidemic
executives
failures
fatty
fda
frenzied
future
gathered
Language
unknown
unset
Current search:
merck
×
abbvie
×
drug
×
" wisconsin top stories "
×
@xconomy.com
4 years ago
Bio Roundup: SeaGen Scores, Dyne’s Debut, Microbiome Moves & More
@xconomy.com
5 years ago
Bio Roundup: Pfizer’s Future, CRISPR in Patients, Drug Imports & More
@xconomy.com
5 years ago
Bio Roundup: Biogen’s Strategy, Drug Price Convo, NASH News & More
@xconomy.com
5 years ago
Pharma CEOs to Senate: We Will Lower Drug Prices if Rebates Go Away
@xconomy.com
5 years ago
Bio Roundup: NASH News, Merck Strikes, Digital Tokens & More